Ekso Bionics Holdings, Inc.
EKSO
$4.63
-$0.10-2.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M |
| Total Depreciation and Amortization | 367.00K | 377.00K | 378.00K | 398.00K | 407.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 281.00K | -1.11M | -202.00K | 1.61M | -144.00K |
| Change in Net Operating Assets | -1.29M | -5.00K | 750.00K | -28.00K | -468.00K |
| Cash from Operations | -2.06M | -3.44M | -1.97M | -1.43M | -2.28M |
| Capital Expenditure | -12.00K | -40.00K | -10.00K | -21.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -40.00K | -10.00K | -21.00K | -8.00K |
| Total Debt Issued | 1.92M | -- | -- | -- | -- |
| Total Debt Repaid | -2.31M | -312.00K | -313.00K | -312.00K | -313.00K |
| Issuance of Common Stock | -- | 928.00K | 3.84M | -- | 5.00M |
| Repurchase of Common Stock | -48.00K | -- | -- | -2.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -437.00K | 616.00K | 3.53M | -314.00K | 4.69M |
| Foreign Exchange rate Adjustments | -10.00K | 56.00K | 7.00K | -31.00K | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.52M | -2.81M | 1.56M | -1.80M | 2.41M |